Segment Information - Schedule of Consolidated Statements of Operations (Details) - Operating Segment [Member] - USD ($) $ in Thousands |
3 Months Ended | |||
|---|---|---|---|---|
Mar. 31, 2025 |
Mar. 31, 2024 |
|||
| Schedule of Consolidated Statements of Operations [Line Items] | ||||
| Salaries and related expenses, other than share-based compensation | $ 1,977 | $ 2,227 | ||
| Clinical trials | 3,626 | 1,734 | ||
| Stock based compensation | 659 | 177 | ||
| Depreciation expenses | 236 | 229 | ||
| Other segment items | [1] | 1,258 | 2,418 | |
| Total Operating expenses | $ 7,756 | $ 6,785 | ||
| ||||
| X | ||||||||||
- Definition Represent the amount of clinical trials. No definition available.
|
| X | ||||||||||
- Definition The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of expense for salary and wage arising from service rendered by officer. Excludes allocated cost, labor-related nonsalary expense, and direct and overhead labor cost included in cost of good and service sold. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of other expense (income) and loss (gain) calculated as difference between segment revenue and separately disclosed expense category to arrive at segment profit (loss). Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition Amount of noncash expense for share-based payment arrangement. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|